BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22129577)

  • 1. Hepatocellular carcinoma in a research subject with ornithine transcarbamylase deficiency.
    Wilson JM; Shchelochkov OA; Gallagher RC; Batshaw ML
    Mol Genet Metab; 2012 Feb; 105(2):263-5. PubMed ID: 22129577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency.
    Raper SE; Yudkoff M; Chirmule N; Gao GP; Nunes F; Haskal ZJ; Furth EE; Propert KJ; Robinson MB; Magosin S; Simoes H; Speicher L; Hughes J; Tazelaar J; Wivel NA; Wilson JM; Batshaw ML
    Hum Gene Ther; 2002 Jan; 13(1):163-75. PubMed ID: 11779420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humanized liver mouse model with transplanted human hepatocytes from patients with ornithine transcarbamylase deficiency.
    Sugahara G; Yamasaki C; Yanagi A; Furukawa S; Ogawa Y; Fukuda A; Enosawa S; Umezawa A; Ishida Y; Tateno C
    J Inherit Metab Dis; 2021 May; 44(3):618-628. PubMed ID: 33336822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term correction of ornithine transcarbamylase deficiency by WPRE-mediated overexpression using a helper-dependent adenovirus.
    Mian A; McCormack WM; Mane V; Kleppe S; Ng P; Finegold M; O'Brien WE; Rodgers JR; Beaudet AL; Lee B
    Mol Ther; 2004 Sep; 10(3):492-9. PubMed ID: 15336649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Exon-Specific Small Nuclear U1 RNA (ExSpeU1) Improves Hepatic OTC Expression in a Splicing-Defective
    Balestra D; Ferrarese M; Lombardi S; Ziliotto N; Branchini A; Petersen N; Bosma P; Pinotti M; van de Graaf SFJ
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228018
    [No Abstract]   [Full Text] [Related]  

  • 6. Correction of ornithine transcarbamylase deficiency in adult spf(ash) mice and in OTC-deficient human hepatocytes with recombinant adenoviruses bearing the CAG promoter.
    Kiwaki K; Kanegae Y; Saito I; Komaki S; Nakamura K; Miyazaki JI; Endo F; Matsuda I
    Hum Gene Ther; 1996 May; 7(7):821-30. PubMed ID: 8860834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evaluation of a clinical candidate AAV8 vector for ornithine transcarbamylase (OTC) deficiency reveals functional enzyme from each persisting vector genome.
    Wang L; Morizono H; Lin J; Bell P; Jones D; McMenamin D; Yu H; Batshaw ML; Wilson JM
    Mol Genet Metab; 2012 Feb; 105(2):203-11. PubMed ID: 22133298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of the liver enzyme ornithine carbamoyltransferase (OTC) in blood: LC-MS/MS assay for non-invasive diagnosis of ornithine carbamoyltransferase deficiency.
    Krijt J; Sokolová J; Ješina P; Dvořáková L; Řeboun M; Brennerová K; Mistrík M; Zeman J; Honzík T; Kožich V
    Clin Chem Lab Med; 2017 Jul; 55(8):1168-1177. PubMed ID: 28107167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vector sequences are not detected in tumor tissue from research subjects with ornithine transcarbamylase deficiency who previously received adenovirus gene transfer.
    Zhong L; Li S; Li M; Xie J; Zhang Y; Lee B; Batshaw ML; Wilson JM; Gao G
    Hum Gene Ther; 2013 Sep; 24(9):814-9. PubMed ID: 24010702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for ornithine transcarbamylase deficiency.
    Kiwaki K; Matsuda I
    Acta Paediatr Jpn; 1996 Apr; 38(2):189-92. PubMed ID: 8677801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperammonemia in ornithine transcarbamylase-deficient recipients following living donor liver transplantation from heterozygous carrier donors.
    Rahayatri TH; Uchida H; Sasaki K; Shigeta T; Hirata Y; Kanazawa H; Mali V; Fukuda A; Sakamoto S; Kasahara M
    Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27891735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired ornithine transcarbamylase deficiency in pediatric and adolescent patients with fibrolamellar hepatocellular carcinoma.
    Bartlett AL; Leslie ND; Gupta A; Geller JI
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27392. PubMed ID: 30094907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperammonemic encephalopathy in a child with ornithine transcarbamylase deficiency due to a novel combined heterozygous mutations.
    Gao J; Gao F; Hong F; Yu H; Jiang P
    Am J Emerg Med; 2015 Mar; 33(3):474.e1-3. PubMed ID: 25227973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperammonemia in a Woman with Late-onset Ornithine Transcarbamylase Deficiency.
    Koya Y; Shibata M; Senju M; Honma Y; Hiura M; Ishii M; Matsumoto S; Harada M
    Intern Med; 2019 Apr; 58(7):937-942. PubMed ID: 30449781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction and prevention of severe hyperammonemia in the spfash mouse model of ornithine transcarbamylase deficiency using shRNA and rAAV-mediated gene delivery.
    Cunningham SC; Kok CY; Dane AP; Carpenter K; Kizana E; Kuchel PW; Alexander IE
    Mol Ther; 2011 May; 19(5):854-9. PubMed ID: 21386824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Application of Next-Generation Sequencing (NGS) in Neonatal-Onset Urea Cycle Disorders (UCDs): Clinical Course, Metabolomic Profiling, and Genetic Findings in Nine Chinese Hyperammonemia Patients.
    Zhou Q; Huang H; Ma L; Zhu T
    Biomed Res Int; 2020; 2020():5690915. PubMed ID: 32934962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency.
    Prieve MG; Harvie P; Monahan SD; Roy D; Li AG; Blevins TL; Paschal AE; Waldheim M; Bell EC; Galperin A; Ella-Menye JR; Houston ME
    Mol Ther; 2018 Mar; 26(3):801-813. PubMed ID: 29433939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AAV gene therapy corrects OTC deficiency and prevents liver fibrosis in aged OTC-knock out heterozygous mice.
    Wang L; Bell P; Morizono H; He Z; Pumbo E; Yu H; White J; Batshaw ML; Wilson JM
    Mol Genet Metab; 2017 Apr; 120(4):299-305. PubMed ID: 28283349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early intervention for late-onset ornithine transcarbamylase deficiency.
    Fujisawa D; Mitsubuchi H; Matsumoto S; Iwai M; Nakamura K; Hoshide R; Harada N; Yoshino M; Endo F
    Pediatr Int; 2015; 57(1):e1-3. PubMed ID: 25711267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotype-Phenotype Correlations in Ornithine Transcarbamylase Deficiency: A Mutation Update.
    Caldovic L; Abdikarim I; Narain S; Tuchman M; Morizono H
    J Genet Genomics; 2015 May; 42(5):181-94. PubMed ID: 26059767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.